🌍 From outbreak surveillance to education, research, and global collaboration, #ISID continues to support infectious disease professionals worldwide through a #OneHealth approach. 👉 Read more in this feature from touchINFECTIOUS DISEASES: ow.ly/70K950Z1caE

👇

Ebola virus disease outbreak in the Democratic Republic of the Congo - ECDC update - 19 May 2026. A large outbreak of Bundibugyo ebolavirus disease is taking place in the Democratic Republic of the Congo (DRC). www.ecdc.europa.eu/en/ebola-vir... 🧵 #Ebola #Bundibugyo #PublicHealth #IdSky #EpiSky

The latest CID supplement issue highlights new innovations in the infectious disease community. ↪️ https://bit.ly/3RaAStQ

In CID, authors developed a #measles transmission model for K-12 public schools in Texas at the school-district-level to estimate the potential risk and size of an unabated major measles outbreak among Texas schoolchildren. https://bit.ly/42NGWef

OFID is seeking research on expanding diagnostic, preventative, and therapeutic strategies to counter the impacts of AMR with a focus in low and middle income countries. Learn more and submit a proposal by June 28: https://bit.ly/3OGh1l1

Developed in alignment with the WHO NPD Road Map 2030 and current global health priorities, this course combines high-level theoretical instruction with extensive hands-on training in a state-of-the-art reference laboratory. Learn more and register today. https://ow.ly/q5zI50YSrOo

Catch up on all things 2025/2026 at the Hot Topics Session! Register now for the MAD-ID & SIDP 2026 Annual Meeting in Orlando, May 14–17 through the link in our bio!

Even the ducks outside Messe München seem ready for tomorrow’s avian flu session 🦆 08:30 at #ESCMIDGlobal2026 | Hall ICM 13a with @escmid.bsky.social , @esgrev-escmid.bsky.social , @isrv.bsky.social, @isirvepi.bsky.social , @ecdc.europa.eu & @ema.europa.eu Early start—but worth it. 🔆

FAO, UNEP, WHO and WOAH meet in Lyon for the Fourth Quadripartite Executive Annual Meeting to advance coordinated global action on One Health. Strengthening collaboration across human, animal, and environmental health is essential to address today’s complex challenges. For more info please see👇

@esgrev-escmid.bsky.social Excited to take on this new challenge with this fantastic team and to contribute to the growth of ESGREV. See you all in Munich at #ESCMIDGlobal2026

Prevention improves wellbeing 🌿 A 2024 Nature Medicine analysis shows that reducing infectious disease burden—through measures like vaccination, ventilation, and hygiene—has measurable benefits for population health & resilience. 🔗 www.nature.com/articles/s41... #Prevention #PublicHealth #VIVI

Epidemiology of HMPV and other respiratory viral infections among outpatients, 2016-2022 ✅ Just Accepted 🔗 https://bit.ly/4sneDhu

🦠 Measles is back. Cases have exploded in 2025 in France, UK, US & Europe due to falling vaccine coverage. The MMR vaccine is ~100% effective with 2 doses. It's saved 94M lives since 1974. Measles isn't just for kids – 34% of US cases were adults over 20. www.pasteur.fr/en/research-... #Measles

🌍 World AMR Awareness Week (#WAAW2025) 🎥 Dr Teske Schoffelen introduces the Abx Guide—a free, open-access database that compiles evidence on pathogen-directed antibiotic treatment. ▶️ Watch: youtu.be/XpN_fRG7pCk @heiman-wertheim.bsky.social @souhakanj.bsky.social

DON'T MISS IT! From Resistance to Resilience: healthcare workers leading the change. Join public health professionals, academia, patients' and NGO's representatives and let's talk about the ways to #KeepAntibioticsWorking! #EAAD2025 online event starts at 1PM CET! Register: bit.ly/EAAD2025Regi...

#Respiratory syncytial virus can cause severe illness especially in infants Data from Belgium, Portugal & Spain show that #immunisation of #children after birth with long-acting monoclonal antibodies 📉 the risk of #hospitalisation due to #RSV infection by ~80% #IDSky #EpiSky #PedSky #MedSky 🛟🧪

You can also find more information about #RSV on the European Vaccination Information Portal - #EVIP in YOUR language! Check it out here: vaccination-info.europa.eu/en/rsv #UnitedInProtection #VaccinesSaveLives #VaccinesWork #ChildHealth #PublicHealth

This winter, raising awareness among healthcare workers & following national recommendations will remain essential to reducing the burden of RSV on infants. Press release: bit.ly/4qSWLex Rapid scientific advice: bit.ly/4hTTNSG Living systematic review: bit.ly/4hVQLxz #IDsky #EpiSky

🛎️

🎓 Jetzt anmelden! Vom 01.–05.12.2025 bietet die Akademie des ZKS Köln wieder den Kurs für Studienkoordination an – als virtuelle Präsenzschulung. Für Study Nurses & Interessierte, die ins Studienmanagement einsteigen wollen. 👉 zks.uni-koeln.de/akademie/kurs-fuer-studienkoordination

📜 At #ESWI2025 Maria Zambon traces the history of how we understand pandemics — from religious interpretations to the rise of rational, evidence-based therapeutics A fascinating look at how science reshaped our view of disease and response🧠 #PublicHealth #Pandemic #History

Immunization against respiratory syncytial virus delivered to infants following birth is safe and provides high antibody levels, regardless of the mother’s RSV vaccination status, according to new research presented at #IDWeek2025. bit.ly/3J9fIbS

✈️ Next stop: #ESWI2025 in Valencia! We’re excited to join global experts in infectious disease control, antimicrobial stewardship, and vaccine innovation. Looking forward to sharing insights, forging collaborations, and advancing prevention together. #VIVI #InfectionPrevention

➡️ Pediatric myocarditis is more often viral and acute, adults more chronic and immune-mediated ➡️ Diagnosis and treatment draw from adult data, leaving major gaps in paediatric evidence CCR Journal Watch - tracking the critical care literature daily criticalcarereviews.com/latest-evide...

There are a few days left to apply for an ESCMID observership! ESCMID is awarding 50 young scientists up to 2K EUR to travel to one of the over 100 collaborative centres for knowledge exchange in the fields of CM & ID! Read more and apply before the deadline on Tuesday, 14 October: ow.ly/95BK50X2GRP

📣🧊 The Trainee Association of ESCMID (TAE) is holding elections for 3 new members in the steering committee. Young Scientist Members (YSM) and LMIC members fulfilling the YSM criteria are eligible to apply. Nominations close 31 October. ow.ly/fHsy50X96Nb

More than pills and shots — your gut microbiome might be a hidden key to vaccine success. 🌿 Recent research shows gut bacteria affect how well our bodies respond to #vaccines. Diet, probiotics, and microbiome health = new frontiers in prevention. #Microbiome #VIVI

Fantastic session on vaccine licensing covering aspects from fighting ongoing outbreaks, limited clinical data, and the current latest developments in the pipeline. Featuring Marco Cavaleri, Sarah Gilbert, Teresa Lambe and Annelies Wilder-Smith. @ema.europa.eu #VaccinesConference #Vaccines #IDSky

🌍 At @ESCMID #VaccinesConference in Lisbon, #Pandemic #Preparedness is in focus (Day 3 & Day 5). From surveillance to vaccines, global cooperation is key to staying ahead of future threats. Prevention today means resilience tomorrow. #UnitedInProtection 👉 bit.ly/ViVI-Prep2025

This week's rapid communications describe ➡️A strain of Neisseria gonorrhoeae producing false negative results on Xpert CT/NG assay in England 🔎An atypical sixfold rise in #influenza A(H1N1)pdm09 cases in Denmark during summer Full issue here 👉 bit.ly/eus2036 #EpiSky #IDSky #MedSky #STISky 🛟🦠🧫⚕️

#JeudiRétro | C’était la polio. Nous nous sommes fait vacciner. Éprouvés. Salvateurs. Les vaccins | www.immunize.ca/sites/defau... #polio #LesVaccinsÇaMarche #LesVaccinsSauventDesVies #FaitesVousVacciner

Welcome back students! Joining us from 29 different countries hailing from 6 continents across the various degree programs are: 72 PhD students, 15 SM1 students, 13 SM1 summer-only students, 62 SM2 students, and 76 MPH Epi students in the Department of Epidemiology @hsph.harvard.edu.

Response to Letter to the Editor, Re: The Effect of Nirmatrelvir-Ritonavir on Short- and Long-term Adverse Outcomes From COVID-19 Among Patients With Kidney Disease: A Propensity Score-Matched Study ✅ Just Accepted #IDSky

Ebola Virus Disease: Uniquely Challenging Among the Viral Hemorrhagic Fevers CCR Journal Watch - tracking the critical care literature daily https://criticalcarereviews.com/latest-evidence/journal-watch

Skin lesions and personal protective equipment (PPE) in healthcare workers from Lima, Peru during the COVID-19 pandemic: a cross-sectional study ✅ Just Accepted #IDSky

🧪 Just 1 week left to apply! ISAC Project Grants 2025 offer up to £15,000 for research in #AMR & #infectiousdiseases 🌍 Projects must involve 2 countries (1 LMIC) 📅 Deadline: 1 Sept 📧 [email protected] 🔗 isac.world #GlobalHealth #ISACGrants @heiman-wertheim.bsky.social @souhakanj.bsky.social

Stopping Spillover at the Source: #OneHealth Meets #Pandemic #Prevention 🛎️ A new roadmap in Emerging Infectious Diseases outlines how investigating and intercepting virus spillovers early—using integrated, cross‑sector efforts (One Health approach)—can help prevent future pandemics. #ActNow

Accurate measurement of viral clearance in early phase antiviral studies in COVID-19 ✅ Just Accepted #IDSky

The 715th Critical Care Reviews Newsletter is now out, covering the latest critical care publications from across the literature over the past week. Sample issue - https://criticalcarereviews.com/newsletters/sample-newsletter Subscribe at - https://criticalcarereviews.com/newsletters/subscribe

Advances in ischemic stroke treatment: current and future therapies CCR Journal Watch - tracking the critical care literature daily https://criticalcarereviews.com/latest-evidence/journal-watch

www.escmid-foundation.org/event-detail... We are pleased to announce this Postgraduate Course co-organised by: @escmid.bsky.social , #EIS, #ESGCIP, #ESGMD, #ESGIE, @esgphm.bsky.social, #EVASG, @esgrev-escmid.bsky.social and the #BIA; Sevilla, Spain, 21-23/10/25. Registration will close July 15.

Stay tuned for the next @ESCMID event! If you are working in vaccines and don’t want to wait until ESCMIDGlobal 2026 in Munich, then check out this vaccine conference in Lisbon in the fall this year.

Allez voir l’infographie créée par Immunisation Canada! | Les vaccins contre la coqueluche durant la #grossesse | immunize.ca/sites/defaul... #coqueluche #LesVaccinsÇaMarche #FaitesVousVacciner

The congress may be ending today but the content can be revisited in our #ESCMIDGlobal replay section. All scientific sessions can be watched or rewatched on the virtual congress platform available for 6 months: ow.ly/f6fP50VzPeU

Last chance at the Vienna Opera House-themed photobooth this year! Create light-hearted moments with colleagues & friends dressed as classical musicians on stage using a variety of entertaining props. #ESCMIDGlobal #IDSky #clinmicro

Kick off day 4 of #ESCMIDGlobal 2025 now in Hall 15! Join experts as they discuss how #climatechange is reshaping the landscape of #infectiousdiseases and the urgent need for adaptation strategies. See you there!

Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations - United States, September 1, 2023-May 31, 2024 ✅ Just Accepted ⭐ Editor's Choice #IDSky

Join Guy Thwaites at 16:15 CEST in Hall 1 at #ESCMIDGlobal 2025 for a deep dive into the current landscape of #tuberculosis treatment, exploring the urgent need for new clinical trials and the potential of host-directed therapies.